----

**SECURITIES      AND EXCHANGE COMMISSION**

**Washington,      D.C. 20549**

**FORM      10-QSB**

**A      J&J PHARMA CORPORATION**

----

|  NEVADA                                                                        |  86-1024812                                    |
|-------------------------------------------------------------------------------------|-----------------------------------------------------|
|  (State                or other jurisdiction of incorporation or organization) | (I.R.S.                Employer Identification No.) |

----

----

----

**A      J&J PHARMA CORPORATION**

**(A      DEVELOPMENT STAGE COMPANY)**

|   **TABLE                OF CONTENTS** |
|--------------------------------------------------|
|                                             |   |   |   |   |   |   |   |   |
|                                             |   |   |   |   |   |   |   | Page |
| Part                I                            | Financial                Information | 3 |
|                                             |   |   |   |   |   |   |   |   |
| Item                1.                           | Financial                Statements: | 3 |
|                                             |   |   |   |   |   |   |   |   |
|                                             | Condensed                Balance Sheets June 30, 2007 (unaudited) and December 31,                2006 | 3 |
|                                             |   |   |
|                                             | Unaudited                Condensed Statements of Operations for the three and six months ended                June 30, 2007 and 2006, and cumulative from inception on July 16,                1998                through June 30, 2007 | 4 |
|                                             |   |   |
|                                             | Unaudited                Condensed Statements of Cash Flows for the six months ended June 30,                2007 and 2006, and cumulative from inception on July 16, 1998 through                June                30, 2007 | 5 |
|                                             |   |   |
|                                             | Statement                of Stockholders' Deficit for the period from July 16, 1998 to June                30,                2007 (unaudited) | 6 |
|                                             |   |   |
|                                             |  Notes                to Financial Statements (unaudited) | 7 |
|                                             |   |   |
| Item                2.                           |  Plan                of Operation | 8 |
|                                             |   |   |
|  Part                II                     |  Other                Information | 8 |
|                                             |   |   |
|  Item                1.                     |  Legal                Proceedings | 8 |
|                                             |   |   |
|  Item                2.                     |  Changes                in Securities | 8 |
|                                             |   |   |
|  Item                6.                     |  Exhibits                and Reports on Form 8-K | 8 |
|                                             |   |   |
|                                             |  Signatures | 8 |

----

| **A.J.                  & J. PHARMA, INC.**                                   |
|-----------------------------------------------------------------------------------------------------------------|
| **(A                  DEVELOPMENT STAGE ENTERPRISE)**                             |
| **CONDENSED                  BALANCE SHEETS**                                     |
|                                                                                                            |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |
|                                                                                                            |   | **June                  30,** | ** ** | ** ** | **December                  31,** | ** ** |
| ** **                                                                                                      | ** ** | **2007** | ** ** | ** ** | **2006** |   |
|                                                                                                            |   | (unaudited) |   |   |   |   |
| **ASSETS**                                                                                                      |
|                                                                                                            |   |   |   |   |   |   |
|  CURRENT                  ASSETS                                                                           |   | $ | - |   |   | $ | - |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
| **LIABILITIES                  AND STOCKHOLDERS' DEFICIT**              |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
| CURRENT                  LIABILITIES                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|        Accounts                  payable, related parties                    |   | $ | 44,453 |   |   | $ | 39,864 |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|        Total                  Current Liabilities                            |   |   | 44,453 |   |   |   | 39,864 |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
| STOCKHOLDERS'                  DEFICIT                                                                          |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
| Common                  stock, par value $.001, 25,000,000                                                      |   |   |   |   |   |   |   |   |
|   shares                  authorized, 1,000,000 issued and                                            |   |   |   |   |   |   |   |   |
|   outstanding                                                                                         |   |   | 1,000 |   |   |   | 1,000 |   |
| Paid                  in capital                                                                                |   |   | 1,800 |   |   |   | 1,800 |   |
|  Accumulated                  deficit during the development stage                                         |   |   | (47,253 | ) |   |   | (42,664 | ) |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
| Total                  Stockholders' accumulated Deficit                                                        |   |   | (44,453 | ) |   |   | (39,864 | ) |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   | $ | - |   |   | $ | - |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
|                                                                                                            |   |   |   |   |   |   |   |   |
| SEE                  ACCOMPANYING NOTES TO FINANCIAL STATEMENTS         |

----

| **A.J.                  & J. PHARMA, INC.**                                  |
|----------------------------------------------------------------------------------|
| **(A                  DEVELOPMENT STAGE ENTERPRISE)**                            |
| **CONDENSED                  STATEMENTS OF OPERATIONS**                          |
| **(UNAUDITED)**                                                                  |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | **Cumulative** | ** ** |
| ** **                                                                       | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | **from** | ** ** |
| ** **                                                                       | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | **July                  16,** | ** ** |
| ** **                                                                       | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | **1998** | ** ** |
| ** **                                                                       | ** ** | **For                  The Three Months Ended** | ** ** | ** ** | **For                  The Six Months Ended** | ** ** | ** ** | **(Inception)** | ** ** |
| ** **                                                                       | ** ** | **June                  30,**** **** **** ** | ** ** | ** ** | **June                  30,**** **** **** ** | ** ** | ** ** | **to** | ** ** |
| ** **                                                                       | ** ** | **2007** | ** ** | ** ** | **2006** | ** ** | ** ** | **2007** | ** ** | ** ** | **2006** | ** ** | ** ** | **June                  30, 2007** |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| REVENUES                                                                         |   | $ | - |   |   | $ | - |   |   | $ | - |   |   | $ | - |   |   | $ | - |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| EXPENSES                                                                         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|    General                  and administrative                    |   |   | 1,729 |   |   |   | 1,372 |   |   |   | 4,589 |   |   |   | 4,060 |   |   |   | 47,253 |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|    Total                  expenses                                |   |   | 1,729 |   |   |   | 1,372 |   |   |   | 4,589 |   |   |   | 4,060 |   |   |   | 47,253 |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| NET                  (LOSS)                                                      |   | $ | (1,729 | ) |   | $ | (1,372 | ) |   | $ | (4,589 | ) |   | $ | (4,060 | ) |   | $ | (47,253 | ) |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| NET                  (LOSS) PER SHARE                                            |   |   | * |   |   |   | * |   |   |   | * |   |   |   | * |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| WEIGHTED                  AVERAGE NUMBER OF                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   COMMON                  SHARES OUTSTANDING                           |   |   | 1,000,000 |   |   |   | 1,000,000 |   |   |   | 1,000,000 |   |   |   | 1,000,000 |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| *                  less than $ (0.01) per share                                  |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| SEE                  ACCOMPANYING NOTES TO FINANCIAL                  STATEMENTS |

----

| **A.J.                  & J. PHARMA, INC.**                                                           |
|-----------------------------------------------------------------------------------------------------------|
| **(A                  DEVELOPMENT STAGE ENTERPRISE)**                                                     |
| **CONDENSED                  STATEMENTS OF CASH FLOWS**                                                   |
| **(UNAUDITED)**                                                                                           |
|                                                                                                      |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   | ** ** | ** ** | ** ** | ** ** | ** ** | **Cumulative** | ** ** |
| ** **                                                                                                | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | **from** | ** ** |
| ** **                                                                                                | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | **July                  16,** | ** ** |
| ** **                                                                                                | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | ** ** | **1998** | ** ** |
| ** **                                                                                                | ** ** | **For                  The Six Months Ended** | ** ** | ** ** | **(Inception)** | ** ** |
| ** **                                                                                                | ** ** | **June                  30,   ** | ** ** | ** ** | **to** | ** ** |
| ** **                                                                                                | ** ** | **2007** | ** ** | ** ** | **2006** | ** ** | ** ** | **June                  30, 2007** |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |
| **OPERATING                  ACTIVITIES**                                                                 |   |   |   |   |   |   |   |   |   |
|          Net                  (loss) from operations         |   | $ | (4,589 | ) |   | $ | (4,060 | ) |   | $ | (47,253 | ) |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
| **NET                  CASH (USED BY) OPERATING ACTIVITIES**                                              |   |   | (4,589 | ) |   |   | (4,060 | ) |   |   | (47,253 | ) |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
| **FINANCING                  ACTIVITIES**                                                                 |   |   |   |   |   |   |   |   |   |   |   |   |
|          Accounts                  payable, related parties  |   |   | 4,589 |   |   |   | 4,060 |   |   |   | 44,453 |   |
|          Proceeds                  from sale of common stock |   |   | - |   |   |   | - |   |   |   | 2,800 |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
| **NET                  CASH PROVIDED BY FINANCING ACTIVITIES**                                            |   |   | 4,589 |   |   |   | 4,060 |   |   |   | 47,253 |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
| **NET                  INCREASE IN CASH**                                                                 |   |   | (0 | ) |   |   | 0 |   |   |   | - |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
| **CASH,                  BEGINNING OF PERIOD**                                                            |   |   | - |   |   |   | - |   |   |   | - |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
| **CASH,                  END OF PERIOD**                                                                  |   | $ | (0 | ) |   | $ | 0 |   |   | $ | - |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                                                      |   |   |   |   |   |   |   |   |   |   |   |   |
| SEE                  ACCOMPANYING NOTES TO FINANCIAL                  STATEMENTS                          |

----

|  **A.J.                & J. PHARMA, INC.**                                |
|------------------------------------------------------------------------------------|
|  **(A                DEVELOPMENT STAGE ENTERPRISE)**                          |
|  **STATEMENT                OF STOCKHOLDERS' DEFICIT**                        |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                               |   |   |   |   |   |   |   |   |  **Accumulated                Deficit** |   |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   | **During                the** |   |   |   |   |
|                                                                               |   |   | **Common                Stock**    |   |   | **Paid-in** |   |   | **Development** |   |   |   |   |
|                                                                               |   |   | **Shares** |   |   | **Amount** |   |   | **Capital** |   |   | **Stage** |   |   | **Total** |   |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| **Balances,                at inception**                                          |   |   | - |   |   | $ | - |   |   | $ | - |   |   | $ | - |   |   | $ | - |   |
| July                16, 1998:                                                      |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Proceeds                from sale of common                                        |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   stock                at $.01 per share                                 |   |   | 200,000 |   |   |   | 200 |   |   |   | 1,800 |   |   |   |   |   |   |   | 2,000 |   |
| Proceeds                from sale of common                                        |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   stock                at par value $.001                                |   |   | 800,000 |   |   |   | 800 |   |   |   |   |   |   |   |   |   |   |   | 800 |   |
|   Net                (loss) for the period                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   | (2,385 | ) |   |   | (2,385 | ) |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| **Balances,                December 31, 1998**                                     |   |   | 1,000,000 |   |   |   | 1,000 |   |   |   | 1,800 |   |   |   | (2,385 | ) |   |   | 415 |   |
|   Net                (loss) for the year                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   | (2,985 | ) |   |   | (2,985 | ) |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| **Balances,                December 31, 1999**                                     |   |   | 1,000,000 |   |   |   | 1,000 |   |   |   | 1,800 |   |   |   | (5,370 | ) |   |   | (2,570 | ) |
|   Net                (loss) for the year                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   | (2,985 | ) |   |   | (2,985 | ) |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| **Balances,                December 31, 2000**                                     |   |   | 1,000,000 |   |   |   | 1,000 |   |   |   | 1,800 |   |   |   | (8,355 | ) |   |   | (5,555 | ) |
|   Net                (loss) for the year                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   | (5,685 | ) |   |   | (5,685 | ) |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| **Balances,                December 31, 2001**                                     |   |   | 1,000,000 |   |   |   | 1,000 |   |   |   | 1,800 |   |   |   | (14,040 | ) |   |   | (11,240 | ) |
|   Net                (loss) for the year                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   | (4,335 | ) |   |   | (4,335 | ) |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| **Balances,                December 31, 2002**                                     |   |   | 1,000,000 |   |   |   | 1,000 |   |   |   | 1,800 |   |   |   | (18,375 | ) |   |   | (15,575 | ) |
|   Net                (loss) for the year                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   | (4,358 | ) |   |   | (4,358 | ) |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| **Balances,                December 31, 2003**                                     |   |   | 1,000,000 |   |   |   | 1,000 |   |   |   | 1,800 |   |   |   | (22,733 | ) |   |   | (19,933 | ) |
|   Net                (loss) for the year                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   | (6,605 | ) |   |   | (6,605 | ) |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| **Balances,                December 31, 2004**                                     |   |   | 1,000,000 |   |   |   | 1,000 |   |   |   | 1,800 |   |   |   | (29,338 | ) |   |   | (26,538 | ) |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Net                (loss) for the year                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   | (6,590 | ) |   |   | (6,590 | ) |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| **Balances,                December 31, 2005**                                     |   |   | 1,000,000 |   |   |   | 1,000 |   |   |   | 1,800 |   |   |   | (35,928 | ) |   |   | (33,128 | ) |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Net                (loss) for the year                                 |   |   |   |   |   |   |   |   |   |   |   |   |   |   | (6,736 | ) |   |   | (6,736 | ) |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| **Balances,                December 31, 2006**                                     |   |   | 1,000,000 |   |   |   | 1,000 |   |   |   | 1,800 |   |   |   | (42,664 | ) |   |   | (39,864 | ) |
| **(unaudited)**                                                                    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Net                (loss) for the six months                           |   |   |   |   |   |   |   |   |   |   |   |   |   |   | (4,589 | ) |   |   | (4,589 | ) |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| **Balances,                June 30, 2007 (unaudited)**                             |   |   | 1,000,000 |   |   | $ | 1,000 |   |   | $ | 1,800 |   |   | $ | (47,253 | ) |   | $ | (44,453 | ) |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|  SEE                ACCOMPANYING NOTES TO FINANCIAL                STATEMENTS |

----

**A.J.        & J. PHARMA, INC.**

**(A          DEVELOPMENT STAGE ENTERPRISE)**

**NOTES          TO FINANCIAL          STATEMENTS**

**Note      1. Basis of Presentation**

**Note      2. Going Concern**

----

| 31.1 | Certificate                of CEO as Required by                Rule 13a-14(a)/15d-14                                                                                                                                                      |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 31.2 | Certificate                of CFO as Required by                Rule 13a-14(a)/15d-14                                                                                                                                                      |
| 32.1 | Certificate                of CEO & CFO as                Required by Rule Rule 13a-14(b) and Rule 15d-14(b) (17 CFR 240.15d-14(b))                and Section 1350 of Chapter 63 of Title 18 of the United States                Code |

----

----